Startups

Director, Toxicology

Vir · San Francisco, California, United States · On-site

← All jobs
About Vir

Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond. Backed by SoftBank VF.

About the role

Vir Biotechnology is seeking an experienced Director, Toxicology to lead nonclinical safety strategies across our infectious disease and oncology portfolio. In this role, you will provide scientific leadership for toxicology and safety assessment activities from candidate selection through clinical development, working closely with cross-functional teams and external partners to advance programs efficiently and effectively.

What they're looking for

  • DVM or PhD in Pharmacology/Toxicology or Biomedical Sciences
  • DABT Certification strongly preferred
  • 12+ years of relevant experience in industry conducting biologics and pharmaceutical research and development, and preferably with oncology and infectious disease biologics specialization
  • Working knowledge of FDA, EMA, and ICH guidance including GLP regulations
  • Experience in authoring regulatory submissions, e.g. INDs, BLA and preparing science-based responses to regulatory inquiries
  • Functional understanding of QA, regulatory, and clinical responsibilities to guide key nonclinical activities, setting up drug candidates for success at all stages of development
More about this role

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN ® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.

Vir Biotechnology has exclusive rights to the universal PRO-XTEN ® masking platform for oncology and infectious disease. PRO-XTEN ® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.

We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.

Vir Biotechnology is seeking an experienced Director, Toxicology to lead nonclinical safety strategies across our infectious disease and oncology portfolio. In this role, you will provide scientific leadership for toxicology and safety assessment activities from candidate selection through clinical...

Read the full posting on Vir's site ↗

Development

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.